IMMUNE-MEDIATED UVEITIS

This adverse event was reported 183 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED UVEITIS:

# Drug Count
0 NIVOLUMAB 128
1 IPILIMUMAB 82
2 PEMBROLIZUMAB 51
3 CARBOPLATIN 13
4 PACLITAXEL 8
5 PACLITAXEL (AIBUMIN-BOUND) 8
6 LEVOTHYROXINE SODIUM 5
7 LEVOTHYROXINE SODIUM ANHYDROUS 5
8 LENVATINIB 4
9 PEMETREXED DISODIUM 4
See all common drugs associated with IMMUNE-MEDIATED UVEITIS

IMMUNE-MEDIATED UVEITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IPILIMUMAB 82 0.0019
1 NIVOLUMAB 128 0.0013
2 PENICILLIN G BENZATHINE 1 0.0007
3 NALDEMEDINE 1 0.0006
4 PEMBROLIZUMAB 51 0.0005
5 ALFUZOSIN HYDROCHLORIDE 1 0.0004
6 PYRIDOSTIGMINE BROMIDE ORAL 1 0.0003
7 ENFORTUMAB VEDOTIN 2 0.0003
8 BINIMETINIB 2 0.0003
9 SILODOSIN 1 0.0002
See all drugs enriched for association with IMMUNE-MEDIATED UVEITIS